Benefits and barriers to integration of chlamydia and gonorrhoea point-of-care testing into remote communities

L Natoli; L Mahler; L Kaldor; J Ward; M Shephard; D Anderson; R Guy

Benefits and barriers to integration of chlamydia and gonorrhoea point-of-care testing into remote communities

L Natoli, L Mahler, L Kaldor, J Ward, M Shephard, D Anderson, R Guy

Research output: Contribution to conference › Paper › peer-review

Abstract

Background: The GeneXpert- is a new molecular point-of-care (POC) test device for diagnosing Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). It recently received regulatory approval in the US, Europe and Australia, and is being used routinely in remote Aboriginal health services in Australia as part of the TTANGO (Test, Treat, ANd GO) Trial. Previously, most CT/NG POC tests have suff ered from being inaccurate and complex.

Original language	English
Pages	15
Number of pages	1
Publication status	Published - 2014
Event	2014 Australasian Sexual Health Conference: Condoms & Beyond, Completing the Sexual Health Picture - Duration: 9 Oct 2014 → …

Conference

Conference	2014 Australasian Sexual Health Conference
Period	9/10/14 → …

Keywords

Chlamydia
Gonorrhoea
Remote Communities

Access to Document

https://ashm.blob.core.windows.net/ashmpublic/2014_ASHM_SexualHealth_Abstracts_Final.pdfLicence: In Copyright

Cite this

@conference{a6df06b2887a46b0b282469319779fc8,

title = "Benefits and barriers to integration of chlamydia and gonorrhoea point-of-care testing into remote communities",

abstract = "Background: The GeneXpert- is a new molecular point-of-care (POC) test device for diagnosing Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). It recently received regulatory approval in the US, Europe and Australia, and is being used routinely in remote Aboriginal health services in Australia as part of the TTANGO (Test, Treat, ANd GO) Trial. Previously, most CT/NG POC tests have suff ered from being inaccurate and complex.",

keywords = "Chlamydia, Gonorrhoea, Remote Communities",

author = "L Natoli and L Mahler and L Kaldor and J Ward and M Shephard and D Anderson and R Guy",

year = "2014",

language = "English",

pages = "15",

note = "2014 Australasian Sexual Health Conference : Condoms & Beyond, Completing the Sexual Health Picture ; Conference date: 09-10-2014",

}

TY - CONF

T1 - Benefits and barriers to integration of chlamydia and gonorrhoea point-of-care testing into remote communities

AU - Natoli, L

AU - Mahler, L

AU - Kaldor, L

AU - Ward, J

AU - Shephard, M

AU - Anderson, D

AU - Guy, R

PY - 2014

Y1 - 2014

N2 - Background: The GeneXpert- is a new molecular point-of-care (POC) test device for diagnosing Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). It recently received regulatory approval in the US, Europe and Australia, and is being used routinely in remote Aboriginal health services in Australia as part of the TTANGO (Test, Treat, ANd GO) Trial. Previously, most CT/NG POC tests have suff ered from being inaccurate and complex.

AB - Background: The GeneXpert- is a new molecular point-of-care (POC) test device for diagnosing Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). It recently received regulatory approval in the US, Europe and Australia, and is being used routinely in remote Aboriginal health services in Australia as part of the TTANGO (Test, Treat, ANd GO) Trial. Previously, most CT/NG POC tests have suff ered from being inaccurate and complex.

KW - Chlamydia

KW - Gonorrhoea

KW - Remote Communities

M3 - Paper

SP - 15

T2 - 2014 Australasian Sexual Health Conference

Y2 - 9 October 2014

ER -

Benefits and barriers to integration of chlamydia and gonorrhoea point-of-care testing into remote communities

Abstract

Conference

Keywords

Access to Document

Fingerprint

Cite this